Publicaciones en colaboración con investigadores/as de Pfizer (United States) (15)

2022

  1. Building a Healthcare Alliance for Resourceful Medicine Offensive Against Neoplasms in Hematology Added Value Framework for Hematologic Malignancies: A Comparative Analysis of Existing Tools

    Value in Health, Vol. 25, Núm. 10, pp. 1760-1767

2020

  1. "There is something you must see": breaking down the remission concept in rheumatoid arthritis from a rheumatologist's perspective

    Clinical and experimental rheumatology, Vol. 38, Núm. 1, pp. 82-87

2017

  1. Exploring the remission concept in rheumatoid arthritis with patients and rheumatologists: Time for a new approach?

    Clinical and Experimental Rheumatology, Vol. 35, Núm. 5, pp. 816-822

2016

  1. Erratum to: Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) (Autophagy, 12, 1, 1-222, 10.1080/15548627.2015.1100356

    Autophagy

  2. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

    Autophagy, Vol. 12, Núm. 1, pp. 1-222

2015

  1. Disability in bipolar i disorder: The 36-item World Health Organization Disability Assessment Schedule 2.0

    Journal of Affective Disorders, Vol. 174, pp. 353-360

2013

  1. The screen for cognitive impairment in psychiatry: Diagnostic-specific standardization in psychiatric ill patients

    BMC Psychiatry, Vol. 13

2012

  1. Guidelines for the use and interpretation of assays for monitoring autophagy

    Autophagy, Vol. 8, Núm. 4, pp. 445-544

  2. Utility of the World Health Organization Disability Assessment Schedule II in schizophrenia

    Schizophrenia Research, Vol. 138, Núm. 2-3, pp. 240-247

2011

  1. Brief cognitive assessment instruments in schizophrenia and bipolar patients, and healthy control subjects: A comparison study between the Brief Cognitive Assessment Tool for Schizophrenia (B-CATS) and the Screen for Cognitive Impairment in Psychiatry (SCIP)

    Schizophrenia Research, Vol. 130, Núm. 1-3, pp. 137-142

2010

  1. Neurocognitive diagnosis and cut-off scores of the Screen for Cognitive Impairment in Psychiatry (SCIP-S)

    Schizophrenia Research, Vol. 116, Núm. 2-3, pp. 243-251

2009

  1. Clinical usefulness of the screen for cognitive impairment in psychiatry (SCIP-S) scale in patients with type I bipolar disorder

    Health and Quality of Life Outcomes, Vol. 7

2008

  1. Spanish version of the Screen for Cognitive Impairment in Psychiatry (SCIP-S): Psychometric properties of a brief scale for cognitive evaluation in schizophrenia

    Schizophrenia Research, Vol. 99, Núm. 1-3, pp. 139-148

2005

  1. Vav1 and Rac control chemokine-promoted T lymphocyte adhesion mediated by the integrin α4β1

    Molecular Biology of the Cell, Vol. 16, Núm. 7, pp. 3223-3235

1995

  1. Structural Studies on the PH Domains of Dbl, Sosl, IRS-1, and βARK1 and Their Differential Binding to Gβγ Subunits

    Biochemistry, Vol. 34, Núm. 28, pp. 9111-9117